Drug Approvals, Upbeat Earnings Help Vertex Pharmaceuticals’ Stock Jump 20% In A MonthForbes • 11/18/19
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell TransplantsGlobeNewsWire • 11/18/19
Vertex Energy, Inc. (VTNR) CEO Benjamin Cowart on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/08/19
Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/31/19
Vertex Energy (VTNR) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 10/29/19
Google, Facebook, AMD Lead 5 Large-Cap Stocks Near Buy Points With Earnings DueInvestors Business Daily • 10/26/19